USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/12364
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBraniste, Alexandru
dc.contributor.authorBraniste, Mariana
dc.contributor.authorStanca, Mihai
dc.contributor.authorFanfaret, Ioan Serban
dc.date.accessioned2020-10-28T08:32:03Z
dc.date.available2020-10-28T08:32:03Z
dc.date.issued2016
dc.identifier.citationBRANISTE, Alexandru, BRANISTE, Mariana, STANCA, Mihai, FANFARET, Ioan Serban. The treatment of superficial bladder tumors with BCG. In: MedEspera: the 6th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2016, p. 171-172.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/12364
dc.descriptionUrology Clinic of Targu Mures County Hospital, Romania, The 6th International Medical Congress for Students and Young Doctors, May 12-14, 2016en_US
dc.description.abstractIntroduction: Bladder cancer is the 5th most common type of neoplasm regarding to incidence. Smoking is the primary risk factor in developing bladder cancer. Previous studies have shown that approximately 70% of the bladder tumors are nonmuscle invasive bladder cancer (NMIBC). Mycobacterium bovis bacillus Calmette-Guerin (BCG) is currently the standard conservative treatment of NMIBC. Material and methods: We performed a retrospective study, conducted during 6 years from 2010 to 2016 at the Urology Clinic of Tg-Mures County Hospital with a total of 78 patients diagnosed with NMIBC.We analyzed the following variables: age, gender, histopathological result, the number of BCG infiltration, in the first six weeks one every week, at three and six months, cystoscopy and the rate of relapse, the main criteria of evaluating the results of the treatment. Results: In the study that we conducted we had a number of 15 women (19,2%) and 63 men (80,8%). At the end of the first six weeks 89,7% of the patients completed all six infiltrations, 70,5% at 3 months and only 60,3% at 6 months. The results of cystoscopy were normal at 70,5%, 25, 6% did not have a cystoscopy performed. Patients were called for investigations first at three months, six months in the first year after finishing the therapy and then every year. In 63,8% of the patients who had the 6 month therapy, no relapse tumor was found in favor of 14,9% with relapse tumor.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectbladder canceren_US
dc.subjectBCG
dc.subjectNMIBC
dc.subjecttherapy
dc.titleThe treatment of superficial bladder tumors with BCGen_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2016

Files in This Item:
File Description SizeFormat 
THE_TREATMENT_OF_SUPERFICIAL_BLADDER_TUMORS_WITH_BCG.PDF40.36 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback